The U.S. Food and Drug Administration (FDA) and drug manufacturer Novo Nordisk are warning consumers about “counterfeit” Ozempic found outside the authorized drug supply chain. The contents of the ...

The FDA issued this alert saying counterfeits have been found in the US drug supply chain. The FDA and the manufacturer ...

A new oral GLP-1 drug candidate could transform the diabetes and weight loss drug boom. Why it matters: Eli Lilly said on ...

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...

Orforglipron, which could become the first GLP-1 pill — a much more convenient option — is a step closer to hitting the ...